Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.01 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.02 |
mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |